TUBA1C and lung adenocarcinoma: Recently, several studies have proposed that TUBA1C is related to poor prognosis in HCC (Wang et al., 2017), pancreatic ductal adenocarcinoma (Albahde et al., 2020), and lung adenocarcinoma (Bian et al., 2021).